Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO2 Study [NA]
Completed clinical trial STRIDE-GO2 evaluating strategies to improve outcomes in gout with low medication adherence; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid [Phase 2]
Phase 2 multi-dose safety and pharmacodynamic study of SEL-212/SEL-037 in symptomatic gout with hyperuricemia has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat [Phase 4]
A Phase 4 comparative effectiveness trial comparing allopurinol vs febuxostat in gout patients, including those with chronic kidney disease;…
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: REduCing Immunogenicity to PegloticasE (RECIPE) Study [Phase 2]
Phase 2 clinical trial RECIPE studying reducing immunogenicity to PegloticasE for gout chronic has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients [Phase 2]
Phase 2 placebo-controlled trial evaluating safety, tolerability, PK, and PD of SAP-001 in gout patients with hyperuricemia completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment [Phase 4]
A Phase 4 safety and efficacy trial of lesinurad 200 mg in participants with gout and renal impairment was terminated; results were posted i…
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect [Phase 2]
Phase 2 trial evaluating tolerization to reduce intolerance to pegloticase and prolong urate-lowering effect in gout.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions [Phase 2]
Phase 2 trial evaluating denosumab in addition to intense urate-lowering therapy for bone erosions in gout patients has completed with poste…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: The Diet Gout Trial [NA]
Clinical trial update for a diet-based intervention in gout and hyperuricemia, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Study of of URC102 to Assess the Efficacy and Safety in Gout Patients [Phase 2]
Phase 2 clinical trial of URC102 in gout has completed; efficacy and safety results are reported.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients [Phase 2]
Phase 2a study of AR882, alone and with febuxostat or allopurinol, in gout patients completed.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout [Phase 4]
A Phase 4 trial evaluating pegylated uricase (pegloticase) plus methotrexate for uncontrolled gout has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout [Phase 2]
Phase 2 trial update for AC-201 controlled-release tablet in gout has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics [Phase 4]
Phase 4 trial investigating how BCRP Q141K affects allopurinol pharmacokinetics and pharmacodynamics in chronic gout and hyperuricemia. Comp…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure [Phase 4]
Phase 4 clinical trial update evaluating the effect of febuxostat on blood pressure in patients with high normal blood pressure and gout; st…
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Virtual Gout Clinic [NA]
A completed clinical trial for a virtual gout clinic sponsored by the University of Alabama at Birmingham with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Novel Methods for Ascertainment of Gout Flares -A Pilot Study [NA]
Pilot study exploring novel methods for ascertainment of gout flares; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia [Phase 2]
Phase II dose-finding study of RDEA3170 versus placebo in Japanese patients with gout or asymptomatic hyperuricemia completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels. [Phase 4]
Phase 4 clinical trial assessing chronic synovial inflammation and its relationship with serum urate levels in gout, with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout [Phase 4]
Phase 4 trial comparing intensive urate lowering with febuxostat vs allopurinol to assess cardiovascular risk in gout patients; results post…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout
An observational study evaluating the use of pegloticase (KRYSTEXXA) in patients with refractory chronic gout; study completed with results …
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: A Single Dose Study of SHR4640 in Healthy Male Volunteers [Phase 1]
A Phase 1 single-dose study of SHR4640 in healthy male volunteers has completed. The sponsor is Atridia Pty Ltd.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES) [Phase 3]
A Phase 3 trial (CARES) comparing the cardiovascular safety of febuxostat versus allopurinol in gout patients with cardiovascular comorbidit…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level [Phase 1]
A Phase 1 multiple-dose study of SHR4640 in male subjects with high serum uric acid levels has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Colchicine Or Naproxen Treatment for ACute gouT [Phase 4]
Phase 4 clinical trial update evaluating colchicine or naproxen treatment for acute gout; study completed with results posted in 2018.